FRANKLIN STREET ADVISORS INC /NC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
FRANKLIN STREET ADVISORS INC /NC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$454,000
-13.2%
16,880
+2.8%
0.07%
-15.4%
Q1 2018$523,000
-15.8%
16,4200.0%0.08%
-16.1%
Q4 2017$621,000
+119.4%
16,420
+43.8%
0.09%
+102.2%
Q3 2017$283,000
+28.6%
11,420
+6.7%
0.05%
+21.1%
Q2 2017$220,000
-51.1%
10,700
-48.3%
0.04%
-51.9%
Q1 2017$450,00020,7000.08%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders